Mary Kay Fenton - 29 Apr 2024 Form 3 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Issuer symbol
CGEM
Transactions as of
29 Apr 2024
Net transactions value
$0
Form type
3
Filing time
30 Apr 2024, 20:58:33 UTC
Previous filing
06 Jul 2023
Next filing
21 Feb 2025

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24 - Power of Attorney